Hims & Hers Health, Inc. (HIMS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 800M 1.6B 2.4B FY19: 82.6M FY20: 148.8M FY21: 271.9M FY22: 526.9M FY23: 872M FY24: 1.5B FY25: 2.3B FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 600M 1.2B 1.8B FY19: 44.6M FY20: 109.5M FY21: 204.5M FY22: 408.7M FY23: 714.9M FY24: 1.2B FY25: 1.7B FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-120M -80M -40M 0 40M 80M 120M FY19: -74.4M FY20: -15.1M FY21: -115M FY22: -68.7M FY23: -29.5M FY24: 61.9M FY25: 105.6M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-150M -100M -50M 0 50M 100M 150M FY19: -72.1M FY20: -18.1M FY21: -107.7M FY22: -65.7M FY23: -23.5M FY24: 126M FY25: 128.4M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 250M 500M 750M FY19: 38M FY20: 39.3M FY21: 67.4M FY22: 118.2M FY23: 157.1M FY24: 303.4M FY25: 614.3M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-150M 0 150M 300M 450M FY19: -74.9M FY20: -2.5M FY21: -34.4M FY22: -26.5M FY23: 73.5M FY24: 251.1M FY25: 300M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-140M -70M 0 70M 140M 210M FY19: -75.2M FY20: -4.2M FY21: -35.2M FY22: -33.7M FY23: 47M FY24: 198.3M FY25: 57.4M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 90M 180M 270M FY19: 34.8M FY20: 35.4M FY21: 186.8M FY22: 204.5M FY23: 209.3M FY24: 236.8M FY25: 258.2M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q4 '20: -0.51 Q1 '21: -0.68 Q2 '21: -0.70 Q3 '21: -0.62 Q4 '21: -0.63 Q1 '22: -0.37 Q2 '22: -0.42 Q3 '22: -0.43 Q4 '22: -0.32 Q1 '23: -0.29 Q2 '23: -0.22 Q3 '23: -0.17 Q4 '23: -0.11 Q1 '24: -0.01 Q2 '24: 0.08 Q3 '24: 0.44 Q4 '24: 0.53 Q1 '25: 0.68 Q2 '25: 0.79 Q3 '25: 0.53 Q4 '25: 0.51 Q1 '26: -0.09 Q2 '26: -0.63 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.